<DOC>
	<DOCNO>NCT01044576</DOCNO>
	<brief_summary>The primary goal research cohort facilitate patient access clinical trial test new therapeutic intervention , access second- line treatment . Secondary objective research cohort study obtain detailed clinical phenotyping immunological analysis blood sample , aim identify validate biomarkers disease activity response treatment prognostic marker .</brief_summary>
	<brief_title>Patient Research Cohort : Rapidly Evolving Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Multiple Sclerosis , Chronic Progressive</mesh_term>
	<criteria>Male Female , age 1865 Able give inform consent Diagnosis MS accord revise McDonald 's criterion ( Polman et al . Ann Neurol 2005 ) Relapsingremitting secondary progressive MS form Disease duration â‰¤15 year diagnosis Expanded disability status scale ( EDSS ) score 2.0 6.0 screen evaluation Highly active and/or treatmentrefractory MS activity define : 1 . Two clinical exacerbation previous 12 month , regardless treatment ; OR : 2 . One clinical exacerbation sustain increase EDSS least 1 point previous 12 month receive immunemodifying treatment , OR : 3 . Evidence gadolinium ( contrast ) enhancement increase T2 lesion load MRI receive immunemodifying treatment . OR 4 . Not tolerate wish receive available immunemodifying treatment meet one state criterion ( b c ) MS activity treat subject ( 1 relapse increase EDSS least 1 point previous 12 month ; evidence contrastenhancement increase T2 lesion load MRI ) . Contraindication MRI include limited intracranial aneurism clip ( except Sugita ) , history intraorbital metal fragment remove MD ( confirm orbital XRay ) , pacemaker nonMR compatible heart valve , inner ear implant , history claustrophobia subject feel unable lie still back period 1.5 hour MRI scanner . If female , positive urine pregnancy test History presence renal impairment ( e.g . serum creatinine clearance le 30ml/min ) Inability give inform consent/comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Multiple Sclerosis</keyword>
</DOC>